These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16148454)

  • 1. The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats.
    McLaughlin PJ; Brown CM; Winston KM; Thakur G; Lu D; Makriyannis A; Salamone JD
    Behav Pharmacol; 2005 Sep; 16(5-6):477-86. PubMed ID: 16148454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats.
    Järbe TU; DiPatrizio NV; Lu D; Makriyannis A
    Behav Pharmacol; 2004 Nov; 15(7):517-21. PubMed ID: 15472574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT
    McLaughlin PJ; Jagielo-Miller JE; Plyler ES; Schutte KK; Vemuri VK; Makriyannis A
    Psychopharmacology (Berl); 2017 Mar; 234(6):1029-1043. PubMed ID: 28144708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of the novel cannabinoid full agonist AM 411.
    McLaughlin PJ; Lu D; Winston KM; Thakur G; Swezey LA; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2005 May; 81(1):78-88. PubMed ID: 15894067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists.
    Hill MN; Froese LM; Morrish AC; Sun JC; Floresco SB
    Psychopharmacology (Berl); 2006 Aug; 187(2):245-59. PubMed ID: 16752140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.
    McLaughlin PJ; Thakur GA; Vemuri VK; McClure ED; Brown CM; Winston KM; Wood JT; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2013 Aug; 109():16-22. PubMed ID: 23603029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.
    Miller RL; Thakur GA; Stewart WN; Bow JP; Bajaj S; Makriyannis A; McLaughlin PJ
    Exp Clin Psychopharmacol; 2013 Oct; 21(5):416-25. PubMed ID: 24099361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
    Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
    Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.
    De Luca MA; Castelli MP; Loi B; Porcu A; Martorelli M; Miliano C; Kellett K; Davidson C; Stair JL; Schifano F; Di Chiara G
    Neuropharmacology; 2016 Jun; 105():630-638. PubMed ID: 26686391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801.
    Presburger G; Robinson JK
    Behav Brain Res; 1999 Feb; 99(1):27-34. PubMed ID: 10512569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
    Ottani A; Leone S; Sandrini M; Ferrari A; Bertolini A
    Eur J Pharmacol; 2006 Feb; 531(1-3):280-1. PubMed ID: 16438952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test.
    Hill MN; Gorzalka BB
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):593-9. PubMed ID: 15916883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.
    Nedaei SE; Rezayof A; Pourmotabbed A; Nasehi M; Zarrindast MR
    Behav Brain Res; 2016 Sep; 311():183-191. PubMed ID: 27230394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys.
    Nakamura-Palacios EM; Winsauer PJ; Moerschbaecher JM
    Behav Pharmacol; 2000 Aug; 11(5):377-86. PubMed ID: 11103889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.
    Hodge J; Bow JP; Plyler KS; Vemuri VK; Wisniecki A; Salamone JD; Makriyannis A; McLaughlin PJ
    Behav Brain Res; 2008 Nov; 193(2):298-305. PubMed ID: 18602425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.